These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 10620136

  • 1. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM.
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [Abstract] [Full Text] [Related]

  • 2. A synthetic C16 omega-hydroxyphytoceramide improves skin barrier functions from diversely perturbed epidermal conditions.
    Oh MJ, Nam JJ, Lee EO, Kim JW, Park CS.
    Arch Dermatol Res; 2016 Oct; 308(8):563-74. PubMed ID: 27402316
    [Abstract] [Full Text] [Related]

  • 3. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, Ahn SK, Brown BE, Elias PM, Feingold KR.
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [Abstract] [Full Text] [Related]

  • 4. Omega-O-acylceramide, a lipid essential for mammalian survival.
    Uchida Y, Holleran WM.
    J Dermatol Sci; 2008 Aug; 51(2):77-87. PubMed ID: 18329855
    [Abstract] [Full Text] [Related]

  • 5. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M, Elias PM, Feingold KR.
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [Abstract] [Full Text] [Related]

  • 6. Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis.
    Akiyama M.
    J Dermatol Sci; 2017 Oct; 88(1):3-9. PubMed ID: 28623042
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of epidermal keratinocytes is dependent on glucosylceramide:ceramide processing.
    Amen N, Mathow D, Rabionet M, Sandhoff R, Langbein L, Gretz N, Jäckel C, Gröne HJ, Jennemann R.
    Hum Mol Genet; 2013 Oct 15; 22(20):4164-79. PubMed ID: 23748427
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM.
    J Clin Invest; 1995 May 15; 95(5):2281-90. PubMed ID: 7738193
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR.
    J Clin Invest; 1991 Oct 15; 88(4):1338-45. PubMed ID: 1918384
    [Abstract] [Full Text] [Related]

  • 12. Sphingolipid metabolism in organotypic mouse keratinocyte cultures.
    Madison KC, Swartzendruber DC, Wertz PW, Downing DT.
    J Invest Dermatol; 1990 Dec 15; 95(6):657-64. PubMed ID: 2123494
    [Abstract] [Full Text] [Related]

  • 13. Glucosylceramides stimulate mitogenesis in aged murine epidermis.
    Marchell NL, Uchida Y, Brown BE, Elias PM, Holleran WM.
    J Invest Dermatol; 1998 Apr 15; 110(4):383-7. PubMed ID: 9540979
    [Abstract] [Full Text] [Related]

  • 14. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK, Feingold KR, Mao-Qiang M, Schaude M, Elias PM.
    J Invest Dermatol; 1992 Feb 15; 98(2):209-19. PubMed ID: 1732385
    [Abstract] [Full Text] [Related]

  • 15. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM.
    J Am Acad Dermatol; 1997 Sep 15; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [Abstract] [Full Text] [Related]

  • 16. Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy.
    Vielhaber G, Pfeiffer S, Brade L, Lindner B, Goldmann T, Vollmer E, Hintze U, Wittern KP, Wepf R.
    J Invest Dermatol; 2001 Nov 15; 117(5):1126-36. PubMed ID: 11710923
    [Abstract] [Full Text] [Related]

  • 17. Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.
    Holleran WM, Uchida Y, Halkier-Sorensen L, Haratake A, Hara M, Epstein JH, Elias PM.
    Photodermatol Photoimmunol Photomed; 1997 Aug 15; 13(4):117-28. PubMed ID: 9453079
    [Abstract] [Full Text] [Related]

  • 18. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M, Jung M, Hong SP, Jeon H, Kim MJ, Cho MY, Lee SH, Man MQ, Elias PM, Choi EH.
    Exp Dermatol; 2010 Jun 15; 19(6):501-10. PubMed ID: 19703225
    [Abstract] [Full Text] [Related]

  • 19. ω-O-Acylceramides but not ω-hydroxy ceramides are required for healthy lamellar phase architecture of skin barrier lipids.
    Opálka L, Meyer JM, Ondrejčeková V, Svatošová L, Radner FPW, Vávrová K.
    J Lipid Res; 2022 Jun 15; 63(6):100226. PubMed ID: 35568253
    [Abstract] [Full Text] [Related]

  • 20. Lipids and barrier function of the skin.
    Wertz PW.
    Acta Derm Venereol Suppl (Stockh); 2000 Jun 15; 208():7-11. PubMed ID: 10884933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.